Blood Coagulation Testing: Increasing Prevalence of Hemostatic Diseases Across The Globe is Projected to Boost The Market Growth During The Forecast Period 2023-2032

Pune, India, March 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global blood coagulation testing market.

Blood Coagulation Testing Market Highlights

The Global Blood coagulation testing market is accounted to register a CAGR of 5.7% during the forecast period and is estimated to reach USD 3.94 billion by 2032.

The global blood coagulation testing market refers to the market for diagnostic tests that assess the blood's ability to clot properly. These tests are crucial in evaluating and monitoring various bleeding and clotting disorders. They help healthcare professionals diagnose conditions such as deep vein thrombosis, hemophilia, von Willebrand disease, and monitor patients on anticoagulant therapy.

Segment Analysis

The Global Blood coagulation testing market has been segmented based Product, Application, and End-User

The market segments of blood coagulation testing, based on Product, includes Clinical laboratory, and Automated. The Clinical laboratory segment held the majority share in 2022 in the Blood Coagulation Testing market data. Additionally, the rise in the number of patients diagnosed with blood disorders and the increasing demand for precise and quick test results further fuel the growth of the clinical laboratory segment. The automated segment, on the other hand, is projected to grow at a rapid rate due to the increasing demand for automated systems that can reduce human error and improve the accuracy of results.

The Blood Coagulation Testing market segmentation, based on application, includes bleeding disorders, and Van Willebrand disease. Bleeding disorders dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The growing prevalence of cardiovascular and blood disorders and the increasing need for timely and accurate diagnosis are expected to drive the market growth further. The rise in investments and government funds for modernizing healthcare facilities, along with the growing focus on research and development, is also expected to contribute to market growth.  

The market data, based on end-user, include academic institutions and hospitals. The hospitals segment dominated the market revenue of blood coagulation testing in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The increased demand for these tests in hospitals is driving the market growth of blood coagulation testing. Additionally, the increasing number of surgical procedures, growing awareness about the significance of coagulation testing, and rising government initiatives to improve healthcare infrastructure are also driving the market growth of the blood coagulation testing in the hospital segment.

Regional Analysis

The Global Blood coagulation testing market, based on region, has been divided into North America, Europe, Asia-Pacific and Rest of the World. North America Blood coagulation testing market accounted for USD 1.145 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. Furthermore, increasing investment by government bodies in the healthcare sector and increasing healthcare awareness among the population are also driving market growth of blood coagulation testing in this region. The increasing demand for cost-effective, accurate and timely coagulation tests is expected to create new growth opportunities for this region's blood coagulation analyzers market. The increase in the number of surgical procedures and blood transfusions, along with the growth of the senior population, is also attributed to the blood coagulation testing market growth.

Europe Blood coagulation testing market accounts for the second-largest market share. The increasing number of research and development activities, government support for healthcare, and the growth of healthcare facilities are further contributing to the market growth of the blood coagulation testing in the region. Moreover, UK market of Blood coagulation testing held the largest market share, and the Germany market of Blood coagulation testing was the fastest-growing market in the region.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Blood Coagulation Testing Market Research Report

Asia Pacific Blood coagulation testing market is expected to grow at the fastest CAGR from 2022 to 2030. The rise in the geriatric population and blood disorders in the Asia-Pacific region has led to an increased demand for coagulation testing, driving the growth of the market for blood coagulation testing in the region. The increasing awareness about the importance of early diagnosis and treatment, along with the growing investments in the healthcare sector in the region, is also expected to drive market growth of blood coagulation testing. Further, the China market of Blood coagulation testing held the largest market share, and the India market of Blood coagulation testing was the fastest growing market in the region.

Key Findings of the Study

• The Global Blood coagulation testing market is expected to reach USD 3.89 billion by 2030, at a CAGR of 5.7% during the forecast period.


• Asia Pacific Blood coagulation testing market is expected to grow at the fastest CAGR from 2022 to 2030.


• The market segments of blood coagulation testing, based on Product, includes Clinical laboratory, and Automated. The Clinical laboratory segment held the majority share in 2022 in the Blood Coagulation Testing market data.


• Danaher, Abbott Laboratories, Bios stem S.A., Helena Laboratories, and Siemens.